Back to Search Start Over

Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study

Authors :
Simó Canonge, Rafael
Bañeras, Jordi
Hernández, Cristina
Rodríguez-Palomares, José
Valente, Filipa
Gutierrez, Laura
González-Alujas, Teresa
Ferreira-Gonzalez, Ignacio
Aguadé-Bruix, Santiago
Montaner, Joan
Seron, Daniel
Genescà, J.
Boixadera Espax, Anna
García Arumí, José
Planas, Alejandra
Simó-Servat, Olga
García-Dorado, David
Universitat Autònoma de Barcelona
[Planas A] Grup de Recerca en Diabetis i Metabolisme, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Servei d’Endocrinologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Simó R, Hernández C, Simó-Servat O] Grup de Diabetis i Metabolisme, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Servei d’Endocrinologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Bañeras J, Rodríguez-Palomares J, Valente F, Gutierrez L, González-Alujas T, Ferreira I, García-Dorado D] Grup de Recerca en Malalties Cardiovasculars, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBER CV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Aguadé-Bruix S] Àrea de Recerca Mèdica i Metabòlica, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Servei de Medicina Nuclear, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Montaner J] Recerca en Malalties Neurovasculars, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Seron D] Recerca en Nefrologia, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Servei de Nefrologia, Vall d'Hebron Hospital, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Red de Investigación Renal, (REDinREN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Genescà J] Recerca en Malalties Hepàtiques, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Servei de Medicina Interna, Vall d'Hebron Hospital, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas, (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Boixadera A, García-Arumí J] Recerca en Oftalmologia, Vall d'Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain.
Vall d'Hebron Barcelona Hospital Campus
Source :
Scientia, Dipòsit Digital de Documents de la UAB, Universitat Autònoma de Barcelona, BMJ Open Diabetes Research & Care
Publication Year :
2019
Publisher :
BMJ, 2019.

Abstract

Type 2 diabetes; Diabetic retinopathy; Subclinical cardiovascular disease Diabetis tipus 2; Retinopatia diabètica; Malalties cardiovasculars subclíniques Diabetes tipo 2; Retinopatía diabética; Enfermedades cardiovasculares subclínicas Objective Detection of subclinical cardiovascular disease (CVD) has significant impact on the management of type 2 diabetes. We examined whether the assessment of diabetic retinopathy (DR) is useful for identifying patients at a higher risk of having silent CVD. Research design and methods Prospective case–control study comprising 200 type 2 diabetic subjects without history of clinical CVD and 60 age-matched non-diabetic subjects. The presence of subclinical CVD was examined using two parameters: (1) calcium coronary score (CACs); (2) composite of CACs >400 UA, carotid plaque ≥3 mm, carotid intima–media thickness ratio >1, or the presence of ECG changes suggestive of previous asymptomatic myocardial infarction. In addition, coronary angio-CT was performed. DR was assessed by slit-lamp biomicroscopy and retinography. Results Type 2 diabetic subjects presented higher CACs than non-diabetic control subjects (p400 (area under the receiver operating characteristic curve (AUROC) 0.76). In addition, an inverse relationship was observed between the degree of DR and CACs

Subjects

Subjects :
Male
cardiovacsular disease(s)
enfermedades nutricionales y metabólicas::enfermedades metabólicas::trastornos del metabolismo de la glucosa::diabetes mellitus::diabetes mellitus tipo II [ENFERMEDADES]
Endocrinology, Diabetes and Metabolism
Type 2 diabetes
Coronary Angiography
Sistema cardiovascular - Malalties
Carotid Intima-Media Thickness
Diabetis no-insulinodependent
Coronary artery disease
0302 clinical medicine
Risk Factors
Prospective Studies
030212 general & internal medicine
Subclinical infection
Cardiovascular Diseases [DISEASES]
Incidence
Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus, Type 2 [DISEASES]
Diabetic retinopathy
Middle Aged
Prognosis
Cardiovascular Diseases
Cardiology
Female
type 2 diabetes
medicine.symptom
enfermedades cardiovasculares::enfermedades vasculares::angiopatías diabéticas::retinopatía diabética [ENFERMEDADES]
Retinopathy
Cardiovascular and Metabolic Risk
medicine.medical_specialty
030209 endocrinology & metabolism
Retinography
Asymptomatic
03 medical and health sciences
Cardiovascular Diseases::Vascular Diseases::Diabetic Angiopathies::Diabetic Retinopathy [DISEASES]
Internal medicine
Diabetes mellitus
retinopathy
medicine
Humans
cardiovascular diseases
Aged
enfermedades cardiovasculares [ENFERMEDADES]
Diabetic Retinopathy
business.industry
medicine.disease
Diabetes Mellitus, Type 2
Spain
Case-Control Studies
Retinopatia diabètica
Tomography, X-Ray Computed
business
Biomarkers
Follow-Up Studies

Details

ISSN :
20524897
Volume :
7
Database :
OpenAIRE
Journal :
BMJ Open Diabetes Research & Care
Accession number :
edsair.doi.dedup.....eb2bc688c6e60ba10c0d614eeb786945